174 related articles for article (PubMed ID: 36219674)
21. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
22. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
Xu X; Liu Y; Weiss S; Arnold E; Sarafianos SG; Ding J
Nucleic Acids Res; 2003 Dec; 31(24):7117-30. PubMed ID: 14654687
[TBL] [Abstract][Full Text] [Related]
23. Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors.
Gao S; Song L; Xu H; Fikatas A; Oeyen M; De Jonghe S; Zhao F; Jing L; Jochmans D; Vangeel L; Cheng Y; Kang D; Neyts J; Herdewijn P; Schols D; Zhan P; Liu X
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615354
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.
Kabinger F; Stiller C; Schmitzová J; Dienemann C; Kokic G; Hillen HS; Höbartner C; Cramer P
Nat Struct Mol Biol; 2021 Sep; 28(9):740-746. PubMed ID: 34381216
[TBL] [Abstract][Full Text] [Related]
25. Incorporation efficiency and inhibition mechanism of 2'-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase.
Yuan C; Goonetilleke EC; Unarta IC; Huang X
Phys Chem Chem Phys; 2021 Sep; 23(36):20117-20128. PubMed ID: 34514487
[TBL] [Abstract][Full Text] [Related]
26. Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
Gao Y; Yan L; Huang Y; Liu F; Zhao Y; Cao L; Wang T; Sun Q; Ming Z; Zhang L; Ge J; Zheng L; Zhang Y; Wang H; Zhu Y; Zhu C; Hu T; Hua T; Zhang B; Yang X; Li J; Yang H; Liu Z; Xu W; Guddat LW; Wang Q; Lou Z; Rao Z
Science; 2020 May; 368(6492):779-782. PubMed ID: 32277040
[TBL] [Abstract][Full Text] [Related]
27. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for substrate selection by the SARS-CoV-2 replicase.
Malone BF; Perry JK; Olinares PDB; Lee HW; Chen J; Appleby TC; Feng JY; Bilello JP; Ng H; Sotiris J; Ebrahim M; Chua EYD; Mendez JH; Eng ET; Landick R; Götte M; Chait BT; Campbell EA; Darst SA
Nature; 2023 Feb; 614(7949):781-787. PubMed ID: 36725929
[TBL] [Abstract][Full Text] [Related]
29. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
[TBL] [Abstract][Full Text] [Related]
30. Viperin, through its radical-SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replication.
Ebrahimi KH; Howie D; Rowbotham JS; McCullagh J; Armstrong FA; James WS
FEBS Lett; 2020 May; 594(10):1624-1630. PubMed ID: 32061099
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 RNA-Dependent RNA Polymerase Follows Asynchronous Translocation Pathway for Viral Transcription and Replication.
Wang X; Xu T; Yao Y; Cheung PP; Gao X; Zhang L
J Phys Chem Lett; 2023 Nov; 14(45):10119-10128. PubMed ID: 37922192
[TBL] [Abstract][Full Text] [Related]
32. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
[TBL] [Abstract][Full Text] [Related]
33. Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp).
Metwally K; Abo-Dya NE; Hamdan AME; Alrashidi MN; Alturki MS; Aly OM; Aljoundi A; Ibrahim M; Soliman MES
Cell Biochem Biophys; 2023 Dec; 81(4):697-706. PubMed ID: 37658974
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
Elfiky AA
J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
Mishra A; Rathore AS
Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
[TBL] [Abstract][Full Text] [Related]
36. Viperin Reveals Its True Function.
Rivera-Serrano EE; Gizzi AS; Arnold JJ; Grove TL; Almo SC; Cameron CE
Annu Rev Virol; 2020 Sep; 7(1):421-446. PubMed ID: 32603630
[TBL] [Abstract][Full Text] [Related]
37. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
[TBL] [Abstract][Full Text] [Related]
38. Characterization of SARS-CoV-2 replication complex elongation and proofreading activity.
Jones AN; Mourão A; Czarna A; Matsuda A; Fino R; Pyrc K; Sattler M; Popowicz GM
Sci Rep; 2022 Jun; 12(1):9593. PubMed ID: 35688849
[TBL] [Abstract][Full Text] [Related]
39. Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant.
Abdalla M; Rabie AM
Comput Biol Chem; 2023 Jun; 104():107768. PubMed ID: 36842392
[TBL] [Abstract][Full Text] [Related]
40. Trapping a non-cognate nucleotide upon initial binding for replication fidelity control in SARS-CoV-2 RNA dependent RNA polymerase.
Romero ME; McElhenney SJ; Yu J
Phys Chem Chem Phys; 2024 Jan; 26(3):1792-1808. PubMed ID: 38168789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
